Doxorubicin-formaldehyde conjugates targeting αvβ3 integrin
Year: 2004
Type: article
Source: Molecular Cancer Therapeutics
Institution: University of Colorado Boulder
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W4292818966
